EA199700185A1 - Способ уменьшения риска вертебральных переломов - Google Patents
Способ уменьшения риска вертебральных переломовInfo
- Publication number
- EA199700185A1 EA199700185A1 EA199700185A EA199700185A EA199700185A1 EA 199700185 A1 EA199700185 A1 EA 199700185A1 EA 199700185 A EA199700185 A EA 199700185A EA 199700185 A EA199700185 A EA 199700185A EA 199700185 A1 EA199700185 A1 EA 199700185A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- fractures
- verbal
- risk
- reducing
- alendronate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Алендронат, бисфосфонат при ежедневном введении в течение значительного периода времени обладает способностью снижать уровень вертебральных переломов у женщин, находящихся в постклимактерическом периоде. Он может снижать число и тяжесть переломов. Введение алендроната может также предупреждать деформирование позвоночника и уменьшение роста.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/389,860 US20010051616A1 (en) | 1995-02-17 | 1995-02-17 | Method of lessening the risk of vertebral fractures |
PCT/US1996/001946 WO1996025166A1 (en) | 1995-02-17 | 1996-02-13 | Method of lessening the risk of vertebral fractures |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199700185A1 true EA199700185A1 (ru) | 1997-12-30 |
EA000348B1 EA000348B1 (ru) | 1999-04-29 |
Family
ID=23540050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199700185A EA000348B1 (ru) | 1995-02-17 | 1996-02-13 | Способ уменьшения риска вертебральных переломов |
Country Status (14)
Country | Link |
---|---|
US (1) | US20010051616A1 (ru) |
EP (1) | EP0809503A4 (ru) |
JP (1) | JPH11501906A (ru) |
KR (1) | KR19980702209A (ru) |
CN (1) | CN1181008A (ru) |
AU (1) | AU689379B2 (ru) |
CA (1) | CA2213076A1 (ru) |
EA (1) | EA000348B1 (ru) |
HU (1) | HUP9802077A3 (ru) |
NZ (1) | NZ303476A (ru) |
PL (1) | PL321836A1 (ru) |
SK (1) | SK111697A3 (ru) |
WO (1) | WO1996025166A1 (ru) |
ZA (1) | ZA961234B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US5994329A (en) | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
WO2000028982A2 (en) * | 1998-11-19 | 2000-05-25 | The Board Of Trustees For The University Of Arkansas | Increasing bone strength with selected bisphosphonates |
KR100317935B1 (ko) * | 1999-10-20 | 2001-12-22 | 유승필 | 대사성 골질환 치료용 약제조성물 및 이의 제조방법 |
HUP0402267A3 (en) * | 2001-12-21 | 2007-05-29 | Procter & Gamble | Method for treatment of bone disorders |
US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
BR0215413A (pt) * | 2001-12-24 | 2004-12-14 | Teva Pharma | Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção |
SI1880744T1 (sl) * | 2002-05-10 | 2015-04-30 | F. Hoffmann-La Roche Ag | Bifosfonske kisline za zdravljenje in prepreäśevanje osteoporoze |
ES2530791T3 (es) | 2002-12-20 | 2015-03-05 | Hoffmann La Roche | Formulación de ibandronato de altas dosis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1201087B (it) * | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
EP0600834A1 (en) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
-
1995
- 1995-02-17 US US08/389,860 patent/US20010051616A1/en not_active Abandoned
-
1996
- 1996-02-13 SK SK1116-97A patent/SK111697A3/sk unknown
- 1996-02-13 JP JP8525097A patent/JPH11501906A/ja active Pending
- 1996-02-13 KR KR1019970705604A patent/KR19980702209A/ko not_active Application Discontinuation
- 1996-02-13 EP EP96906412A patent/EP0809503A4/en not_active Withdrawn
- 1996-02-13 AU AU49799/96A patent/AU689379B2/en not_active Ceased
- 1996-02-13 EA EA199700185A patent/EA000348B1/ru not_active IP Right Cessation
- 1996-02-13 CA CA002213076A patent/CA2213076A1/en not_active Abandoned
- 1996-02-13 WO PCT/US1996/001946 patent/WO1996025166A1/en not_active Application Discontinuation
- 1996-02-13 HU HU9802077A patent/HUP9802077A3/hu unknown
- 1996-02-13 NZ NZ303476A patent/NZ303476A/en unknown
- 1996-02-13 PL PL96321836A patent/PL321836A1/xx unknown
- 1996-02-13 CN CN96193121A patent/CN1181008A/zh active Pending
- 1996-02-16 ZA ZA961234A patent/ZA961234B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MX9706275A (es) | 1997-11-29 |
HUP9802077A2 (hu) | 2000-06-28 |
EP0809503A4 (en) | 2001-12-05 |
CN1181008A (zh) | 1998-05-06 |
AU689379B2 (en) | 1998-03-26 |
WO1996025166A1 (en) | 1996-08-22 |
EP0809503A1 (en) | 1997-12-03 |
KR19980702209A (ko) | 1998-07-15 |
JPH11501906A (ja) | 1999-02-16 |
HUP9802077A3 (en) | 2001-10-29 |
SK111697A3 (en) | 1998-02-04 |
NZ303476A (en) | 2000-07-28 |
US20010051616A1 (en) | 2001-12-13 |
EA000348B1 (ru) | 1999-04-29 |
CA2213076A1 (en) | 1996-08-22 |
ZA961234B (en) | 1996-08-27 |
PL321836A1 (en) | 1997-12-22 |
AU4979996A (en) | 1996-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0830138A4 (en) | USE OF FIBROBLAST GROWTH FACTORS TO STIMULATE BONE GROWTH | |
ZA964816B (en) | Implant for the surgical treatment of a vertebral isthmus fracture. | |
CA2184916A1 (en) | Use of fibroblast growth factors to stimulate bone growth | |
FR2705235B1 (fr) | Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os. | |
CA2262269A1 (en) | Treatment of skeletal disorders | |
PL341112A1 (en) | Methods of providing postmenopausal treatment to female patients using very low doses of oestrogen | |
DE69616376D1 (de) | Verwendung von Tiagabin zur Behandlung von Schlafstörungen | |
EP0748634A3 (de) | Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung | |
AU1432795A (en) | Devices and methods for posterior spinal fixation | |
NO952131L (no) | Fremgangsmåte for behandling av et kirurgisk metallimplantat | |
EA199700183A1 (ru) | Способ уменьшения риска невертебральных переломов костей | |
EA199700185A1 (ru) | Способ уменьшения риска вертебральных переломов | |
MX9703944A (es) | Metodo para usar derivados de triaril-etileno en el tratamiento y prevencion de osteoporosis. | |
AU7357596A (en) | Surgical system and method for the reattachment of soft tiss ue to bone | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
AU2534595A (en) | Angiotensin ii for improving fertilization | |
EP0779812A4 (en) | METHOD FOR TREATING OSTEOPOROSIS USING BONE-ACTIVE PHOSPHONATES AND PARATHORMONE | |
EP0841878A4 (en) | DENTAL IMPLANT DEVICE | |
EP0828507A4 (en) | METHOD FOR TREATING PAIN | |
AU3607293A (en) | Implant therapy for bone growth stimulation | |
EP0904094A4 (en) | TREATMENT OF BONE DISEASES USING ADRENOMEDULLINE | |
IL126158A0 (en) | Method for treating substance abuse | |
CA2177595A1 (en) | Metallic implant and process for treating a metallic implant | |
UA29186A (ru) | Способ лечения постменопаузального остеопороза | |
TH24700A (th) | " วิธีการลดความเสี่ยงของการแตกหักกระดูกสันหลังและที่ไม่เป็นกระดูกสันหลัง " |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KZ KG TJ TM RU |